BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $478,000 | -65.1% | 310,000 | -66.5% | 0.02% | -64.7% |
| Q1 2015 | $1,368,000 | +28.7% | 925,000 | +2.8% | 0.05% | +4.1% |
| Q4 2014 | $1,063,000 | -56.7% | 900,000 | -60.9% | 0.05% | -50.5% |
| Q3 2014 | $2,455,000 | +82.5% | 2,300,000 | +76.9% | 0.10% | +86.8% |
| Q2 2014 | $1,345,000 | -5.5% | 1,300,000 | 0.0% | 0.05% | -10.2% |
| Q1 2014 | $1,423,000 | +47.9% | 1,300,000 | +44.4% | 0.06% | +43.9% |
| Q4 2013 | $962,000 | – | 900,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 5,000,000 | $5,356,000 | 2.91% |
| Lombard Odier Asset Management (Europe) Ltd | 31,900,000 | $34,087,000 | 2.41% |
| SHENKMAN CAPITAL MANAGEMENT INC | 15,970,000 | $16,929,000 | 1.92% |
| MACKAY SHIELDS LLC | 24,283,000 | $25,802,000 | 1.34% |
| Verition Fund Management LLC | 7,982,000 | $8,491,000 | 1.20% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 62,750,000 | $66,638,000 | 1.03% |
| OAKTREE CAPITAL MANAGEMENT LP | 34,510,000 | $37,002,000 | 0.61% |
| Jabre Capital Partners S.A. | 3,500,000 | $3,722,000 | 0.32% |
| Calamos Wealth Management LLC | 656,000 | $695,000 | 0.20% |
| Baker Brothers Advisors | 12,500,000 | $13,203,000 | 0.17% |